[1] Endo K, Kuroda H, Oikawa T,et al.Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma.Scand J Gastroenterol,2018,21:1-9.
[2] Sparchez Z, Mocan T, Radu P, et al.Prognostic factors after percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma. Impact of incomplete ablation on recurrence and overall survival rates.J Gastrointestin Liver Dis,2018,27:399-407.
[3] Nam K, Stanczak M, Lyshchik A, et al.Evaluation of hepatocellular carcinoma transarterial chemoembolization using quantitative analysis of 2D and 3D real-time contrast enhanced ultrasound.Biomed Phys Eng Express,2018,4:035039.
[4] Cao J, Dong Y, Mao F, et al.Dynamic three-dimensional contrast-enhanced ultrasound to predict therapeutic response of radiofrequency ablation in hepatocellular carcinoma: preliminary findings.Biomed Res Int,2018,2018:6469703.
[5] 袁惠,牛锦东,张梓桢,等.三维超声造影对肝癌射频治疗的评价.中国超声医学杂志,2015,31:521-523.
[6] Bartolotta TV, Taibbi A, Matranga D, et al.3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.Radiol Med,2015,120:695-704.
[7] Lu Y, Liu B, Zheng Y, et al.Application of real-time three-dimensional contrast-enhanced ultrasound using SonoVue for the evaluation of focal liver lesions: a prospective single-center study.Am J Transl Res,2018,10:1469-1480.
[8] 陈露阳,廖锦堂,齐文君,等.动态三维超声造影评价肝癌射频消融术疗效的价值.中华医学超声杂志(电子版),2017,14:193-199.
[9] 王晓东,赵萍.二维与三维超声造影在原发性肝癌射频治疗中的应用比较.中山大学学报(医学科学版),2014,35:602-606. |
